> **Detailed** **info** **on** **viro-Ai:**

**1.** **Title** **of** **the** **Invention**

Viro-AI: An AI/ML System for Proactive Viral Threat Management and
Antidote Discovery.

**2.** **Field** **of** **Invention**

The invention relates to the field of artificial intelligence and
machine learning in medicine, specifically for the rapid analysis,
prediction, and management of viral threats and the acceleration of the
drug discovery process.

**3.** **Executive** **Summary** **/** **Abstract**

Viro-AI is a revolutionary AI and machine learning-powered system
designed to assist pharmaceutical and biological researchers in the
rapid analysis, prediction, and management of viral threats. By
leveraging vast, interconnected datasets of historical and contemporary
viral information, genetic structures, and treatment outcomes, the
system aims to accelerate the drug discovery process. Its core
functionality includes proactive mutation prediction, targeted antidote
generation, and high-fidelity simulations of viral behavior and drug
interaction. This initiative seeks to significantly reduce the time and
resources required to combat emerging diseases, thereby revolutionizing
global health security. The system is designed for pharmacy and
biotechnology professionals, including virologists, pharmacologists, and
researchers.

**4.** **Detailed** **Description** **of** **the** **Invention**

**A.** **System** **Architecture** **&** **Data** **Handling**

The foundation of the Viro-AI system is its comprehensive and
continuously updated knowledge base. The prototype requires a large 30GB
dataset and the team has prepared a data handling strategy to manage
this eficiently, including data streaming and batch processing. The data
is organized into three main directories:

> • **Genomic** **Data:** Contains genetic sequences and mutations from
> sources like GenBank (NCBI) and GISAID. Files include raw sequences in
> .gb format and variants in .fasta format.
>
> • **Structural** **Data:** Houses 3D structural data of viral proteins
> from the RCSB Protein Data Bank (PDB) and VPDB. The data is stored in
> .pdb format, which is crucial for antidote screening and 3D
> visualization.
>
> • **Clinical** **&** **Pharmaceutical** **Data:** Includes reports on
> treatment eficacy, clinical outcomes, and pharmaceutical data from
> sources like the WHO Global Health Observatory and PubMed/PMC. This
> data is structured into usable formats such as .csv.

The system will use libraries such as Dask or Apache Spark to handle the
large dataset in manageable chunks, along with other libraries like
Pandas and NumPy for data manipulation.

**B.** **Predictive** **&** **Analytical** **Engine**

The system's central component is a powerful AI/ML engine that processes
and analyzes new viral threats. The primary workflow is as follows:

> • **Input** **from** **Researchers:** Professionals provide detailed
> input on newly discovered viruses, including text descriptions, 3D
> structural data, and their impact on human DNA and proteins.
>
> • **Antidote** **Formula** **Generation:** The system analyzes the new
> virus and its characteristics against historical treatment data. It
> then proposes potential antidote formulas with a minimum accuracy of
> over 70% by identifying and suggesting modifications to existing
> successful formulas.
>
> • **Predictive** **Modeling:** Viro-AI will predict the behavior and
> deadly mutations of the new virus in various environmental conditions
> with an accuracy of over 69% from its initial state. The key output
> for this module is a "Deadliness" score on a scale of 1-100.

**C.** **Simulation** **&** **Visualization** **Module**

The Viro-AI system includes an advanced simulation module to model how
potential treatments interact with a virus. This module generates a
real-time, dynamic 3D visualization of the proposed antidote docking
with the viral protein. This is a crucial step for pre-clinical
validation, allowing researchers to refine formulas before physical
testing.

**5.** **Technology** **Stack**

The project utilizes a specific set of libraries and algorithms to
achieve its functionalities:

> • **Data** **Handling:** Dask or Apache Spark for distributed
> computing, Pandas for data manipulation, and HDF5 for storage.
>
> • **Mutation** **Prediction** **Engine:** Scikit-learn for machine
> learning, and TensorFlow/Keras or PyTorch for deep learning.
>
> • **Antidote** **Screening** **Module:** RDKit for molecular
> descriptors and molecular docking algorithms such as AutoDock or Vina.
>
> • **3D** **Visualization** **&** **Simulation:** PyVista and Open3D
> for 3D processing and visualization, and Plotly for interactive plots.
>
> • **Backend** **&** **Web** **Interface:** Flask or FastAPI for the
> web framework and Streamlit or Dash for interactive web apps.

**6.** **Claims**

The following claims are drafted to highlight the novel and inventive
aspects of the Viro-AI system, distinguishing it from existing
technologies.

**Claim** **1:** **A** **system** **for** **proactive** **viral**
**threat** **management,** **comprising:**

> • A data ingestion module configured to receive and partition a large
> dataset (e.g., 30GB or more) comprising viral genomic data, 3D
> structural data, and pharmaceutical data.
>
> • A predictive engine configured to analyze the genomic data and
> predict future mutations of a virus with a predetermined accuracy.
>
> • An antidote generation module configured to screen a library of
> pharmaceutical data and propose potential antidote formulas with a
> predetermined accuracy by suggesting modifications to existing
> compounds.
>
> • A simulation module configured to generate a dynamic 3D
> visualization of a proposed antidote docking with a viral protein.

**Claim** **2:** **The** **system** **of** **claim** **1,** **wherein**
**the** **predictive** **engine** **is** **further** **configured**
**to:**

> • Analyze the relationship between a virus's genetic sequences and its
> historical clinical outcomes.
>
> • Assign a "Deadliness" score to a predicted mutation based on the
> analysis.
>
> • Generate a "what-if" scenario demonstrating a likely future mutation
> of a known virus.

**Claim** **3:** **The** **system** **of** **claim** **1,** **wherein**
**the** **antidote** **generation** **module** **is** **further**
**configured** **to:**

> • Use a binding afinity model to rank potential antidote candidates.
>
> • Suggest small, AI-driven modifications to the chemical structure of
> a top-ranked candidate to improve its effectiveness.

**Claim** **4:** **The** **system** **of** **claim** **1,** **wherein**
**the** **data** **ingestion** **module** **is** **configured** **to**
**process** **the** **dataset** **using** **data** **streaming** **or**
**batch** **processing** **to** **avoid** **loading** **the** **entire**
**dataset** **into** **memory.**
